Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Silicone Breast Implant Approvals Conditioned On Huge Postmarket Studies

This article was originally published in The Gray Sheet

Executive Summary

FDA's Nov. 17 approval of silicone-gel breast implants comes with the requirement for one of the largest post-approval studies ever called for by the device center, according to CDRH Director Dan Schultz
Advertisement

Related Content

Study Highlights Autoimmune, CTD Issues In Women Who Had Breast Implants
New Products In Brief
FDA Announces Possible Link Between Breast Implants And Cancer
FDA Announces Possible Link Between Breast Implants And Cancer
Congresswoman Questions FDA Decision On Mentor Implant Study
Congresswoman Questions FDA Decision On Mentor Implant Study
Allergan’s Aesthetic Device Lineup Gains Momentum In 2nd Quarter
Allergan’s Aesthetic Device Lineup Gains Momentum In 2nd Quarter
Sales Of Silicone Breast Implants To Easily Offset Post-Approval Study Costs
Sales Of Silicone Breast Implants To Easily Offset Post-Approval Study Costs
Advertisement
UsernamePublicRestriction

Register

MT024215

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel